Single vs. Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Intervention With DCB-only Strategy (KONG-FREEDOM-I)

חו"ל (דורש נסיעה)מגייס משתתפים

מצבים רפואיים

Coronary Heart Disease (CHD)

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Beijing Luhe Hospital, Beijing, Beijing Municipality, China

  • The First Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China

  • The 2nd Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China

  • The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China

  • Heze Municipal Hospital, Heze, Shandong, China

  • Shandong Provincial Hospital, Jinan, Shandong, China

  • Shandong Provincial Third Hospital, Jinan, Shandong, China

    Contact: Study coordinator (Wei Zhou) · zhouguo321@126.com · + 86 15853166471
  • Affiliated Hospital of Jining Medical University, Jining, Shandong, China

    Contact: Study coordinator (Lijun Gan) · 13792336453@163.com
  • Liaocheng People's Hospital, Liaocheng, Shandong, China

  • Qingdao Municipal Hospital, Qingdao, Shandong, China

    Contact: Study coordinator (Wei Xia) · 18669710958@163.com · +86 18669710958
  • Tai'an City Central Hospital, Tai’an, Shandong, China

  • Zaozhuang Municipal Hospital, Zaozhuang, Shandong, China

  • Shanghai Fengxian District People's Hospital, Shanghai, Shanghai Municipality, China

  • The First Affiliated Hospital of Xinjiang Medical University, Ürümqi, Xinjiang, China